I. Logeart

2.8k citations

46 papers · 1.9k indexed · 1 hit paper · h-index 24

Rheumatology top 0.5%
Surgery top 10%
Immunology top 5%
Hematology top 2%
Pharmacology top 5%

Co-authors: Maxime Dougados Philippe Ravaud Florence Tubach Bernard Combe Gabriel Baron Désirée van der Heijde E. Martín‐Mola H Awada
Topics: Rheumatoid Arthritis Research and Therapies (36 papers)Spondyloarthritis Studies and Treatments (23 papers)Autoimmune and Inflammatory Disorders Research (8 papers)
Cited by: Rheumatology Hematology Orthopedics and Sports Medicine
Journals: Annals of the Rheumatic Diseases Lara D. Veeken Arthritis Research & Therapy
Partner nations: France Netherlands United States

In The Last Decade

I. Logeart

45 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: Results from a prospective multinational study

2012 316 citations Florence Tubach, Philippe Ravaud et al. profile →

Peers

Countries citing papers authored by I. Logeart

Since Specialization

Citations

This map shows the geographic impact of I. Logeart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Logeart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Logeart more than expected).

Fields of papers citing papers by I. Logeart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Logeart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Logeart. The network helps show where I. Logeart may publish in the future.

Co-authorship network of co-authors of I. Logeart

This figure shows the co-authorship network connecting the top 25 collaborators of I. Logeart. A scholar is included among the top collaborators of I. Logeart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Logeart. I. Logeart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluation of the change in structural radiographic sacroiliac joint damage after 2 years of etanercept therapy (EMBARK trial) in comparison to a contemporary control cohort (DESIR cohort) in recent onset axial spondyloarthritis 2018 ·Annals of the Rheumatic Diseases ·Maxime Dougados,Walter P. Maksymowych,Robert Landewé,Anna Moltó,Pascal Claudepierre,Manouk de Hooge,R. Lambert,R. Bonin,Jack F. Bukowski,Heather Jones,I. Logeart,Ron Pedersen,Annette Szumski,Bonnie Vlahos,Désirée van der Heijde	33
2	The Minimum Clinically Important Improvement and Patient-acceptable Symptom State in the BASDAI and BASFI for Patients with Ankylosing Spondylitis 2016 ·The Journal of Rheumatology ·(unknown),Sofía Ramiro,Robert Landewé,Maxime Dougados,Florence Tubach,Nicholas Bellamy,Marc C. Hochberg,Philippe Ravaud,E. Martín‐Mola,H Awada,Claire Bombardier,David T. Felson,N. Hajjaj‐Hassouni,I. Logeart,Marco Matucci‐Cerinic,Mart van de Laar,Désirée van der Heijde	41
3	Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study 2015 ·Annals of the Rheumatic Diseases ·Walter P. Maksymowych,Maxime Dougados,Désirée van der Heijde,Joachim Sieper,Jürgen Braun,Gustavo Citera,Filip Van den Bosch,I. Logeart,Joseph Wajdula,Heather Jones,Lisa Marshall,R. Bonin,Ron Pedersen,Bonnie Vlahos,Sameer Kotak,Jack F. Bukowski	80
4	When to Adjust Therapy in Patients with Rheumatoid Arthritis After Initiation of Etanercept plus Methotrexate or Methotrexate Alone: Findings from a Randomized Study (COMET) 2014 ·The Journal of Rheumatology ·(unknown),Désirée van der Heijde,Y. Brault,Andrew Koenig,I. Logeart	8
5	Retention rates of adalimumab, etanercept and infliximab as first and second-line biotherapy in patients with rheumatoid arthritis in daily practice 2014 ·Joint Bone Spine ·Aline Frazier,Maxime Dougados,Xavier Mariette,Alain Cantagrel,(unknown),R.M. Flipo,I. Logeart,Thierry Schaeverbeke,Jean Sibilia,Xavier Le Loët,Bernard Combe	34
6	Five-year Favorable Outcome of Patients with Early Rheumatoid Arthritis in the 2000s: Data from the ESPOIR Cohort 2013 ·The Journal of Rheumatology ·Bernard Combe,Nathalie Rincheval,Joëlle Bénessiano,Francis Bérenbaum,Alain Cantagrel,Jean‐Pierre Daurès,Maxime Dougados,Patrice Fardellone,Bruno Fautrel,R.M. Flipo,Philippe Goupille,Françis Guillemin,Xavier Le Loët,I. Logeart,Xavier Mariette,Olivier Meyer,Philippe Ravaud,Alain Saraux,Thierry Schaeverbeke,Jean Sibilia	36
7	Defining cut-off values for disease activity states and improvement scores for patient-reported outcomes: the example of the Rheumatoid Arthritis Impact of Disease (RAID) 2012 ·Arthritis Research & Therapy ·Maxime Dougados,Y. Brault,I. Logeart,Désirée van der Heijde,Laure Gossec,Tore K Kvien	59
8	Continuous efficacy of etanercept in severe and advanced ankylosing spondylitis: results from a 12-week open-label extension of the SPINE study 2012 ·Lara D. Veeken ·(unknown),Jürgen Braun,Sándor Szántó,Bernard Combe,Pál Géher,Véronique Leblanc,I. Logeart	25
9	Predictors of radiographic progression in the ESPOIR cohort: the season of first symptoms may influence the short-term outcome in early arthritis 2011 ·Annals of the Rheumatic Diseases ·Gaël Mouterde,Cédric Lukas,I. Logeart,(unknown),Nathalie Rincheval,J.P. Daurès,Bernard Combe	37
10	The Influence of the Definition of Patient Global Assessment in Assessment of Disease Activity According to the Disease Activity Score (DAS28) in Rheumatoid Arthritis 2011 ·The Journal of Rheumatology ·Maxime Dougados,(unknown),Pascal Hilliquin,Patrice Fardellone,Olivier Brocq,Y. Brault,I. Logeart	14
11	Metrologic properties of ultrasound versus clinical evaluation of synovitis in rheumatoid arthritis: Results of a multicenter, randomized study 2011 ·Arthritis & Rheumatism ·Péter Mandl,Péter Bálint,Y. Brault,M. Backhaus,Maria Antonietta D’Agostino,Walter Grassi,Désirée van der Heijde,Eugenio de Miguel,Richard J. Wakefield,I. Logeart,Maxime Dougados	41
12	Validation of a numerical rating scale to assess functional impairment in hip and knee osteoarthritis: comparison with the WOMAC function scale 2010 ·Annals of the Rheumatic Diseases ·Paul Ornetti,(unknown),S. Paternotte,I. Logeart,Laure Gossec	67
13	Factors determining a DMARD initiation in early inflammatory arthritis patients. The ESPOIR cohort study. 2009 ·PubMed ·Cédric Lukas,Francis Guillemin,Robert Landewé,Désirée van der Heijde,I. Logeart,Bruno Fautrel,J.P. Daurès,Bernard Combe,(unknown)	13
14	Individualising the Western Ontario and McMaster Universities osteoarthritis index (WOMAC) function subscale: incorporating patient priorities for improvement to measure functional impairment in hip or knee osteoarthritis 2007 ·Annals of the Rheumatic Diseases ·Raphaèle Séror,Florence Tubach,Gabriel Baron,Bruno Falissard,I. Logeart,Maxime Dougados,Philippe Ravaud	16
15	Short-Term Efficacy of Rofecoxib and Diclofenac in Acute Shoulder Pain: A Placebo-Controlled Randomized Trial 2007 ·PubMed ·Maxime Dougados,Anne Le Hénanff,I. Logeart,Philippe Ravaud	13
16	The ESPOIR cohort: A ten-year follow-up of early arthritis in France 2007 ·Joint Bone Spine ·Bernard Combe,Joëlle Bénessiano,Francis Bérenbaum,Alain Cantagrel,Jean‐Pierre Daurès,Maxime Dougados,Patrice Fardellone,Bruno Fautrel,René‐Marc Flipo,Philippe Goupille,Françis Guillemin,Xavier Le Loët,I. Logeart,Xavier Mariette,O Meyer,Philippe Ravaud,Nathalie Rincheval,Alain Saraux,Thierry Schaeverbeke,Jean Sibilia	135
17	Feeling good rather than feeling better matters more to patients 2006 ·Arthritis Care & Research ·Florence Tubach,Maxime Dougados,Bruno Falissard,Gabriel Baron,I. Logeart,Philippe Ravaud	162
18	Prescription du rofécoxib en pratique médicale courante : résultats d'une enquête française 2004 ·La Revue de Médecine Interne ·B Bannwarth,I. Logeart,(unknown)	1
19	Evaluation of clinically relevant changes and states in symptomatic outcome variables in osteoarthritis 2003 ·Queensland's institutional digital repository (The University of Queensland) ·Florence Tubach,Gabriel Baron,Philippe Ravaud,Bruno Falissard,I. Logeart,(unknown),David T. Felson,D. van der Heijde,M. Hochberg,N. Bellamy,Maxime Dougados	5
20	Naturalistic survey on nonsteroidal antiinflammatory treatment in patients with musculoskeletal pain 2003 ·Joint Bone Spine ·Philippe Goupille,I. Logeart,Bernard Combe	4

About I. Logeart

I. Logeart is a scholar working on Rheumatology, Hematology and Pharmacology, having authored 46 papers that have together received 1.9k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (36 papers), Spondyloarthritis Studies and Treatments (23 papers) and Autoimmune and Inflammatory Disorders Research (8 papers). The work is most often cited by research in Rheumatology (1.4k citations), Hematology (372 citations) and Orthopedics and Sports Medicine (194 citations). I. Logeart has collaborated with scholars based in France, Netherlands and United States. Frequent co-authors include Maxime Dougados, Philippe Ravaud, Florence Tubach, Maxime Dougados, Bernard Combe, Gabriel Baron, Désirée van der Heijde, E. Martín‐Mola, H Awada and N. Hajjaj‐Hassouni. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Arthritis Research & Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact